By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


SEARCH JOBS








Company News
CEL-SCI (CVM) Has Been Cleared to Begin Patient Enrollment 7/23/2014 12:59:40 PM
CEL-SCI (CVM) Expands Its Phase 3 Head And Neck Cancer Trial Into Sri Lanka 7/17/2014 7:57:45 AM
CEL-SCI (CVM) Receives $225,000 National Institutes of Health (NIH) Research Grant To Develop Rheumatoid Arthritis Treatment 7/15/2014 7:45:53 AM
CEL-SCI (CVM) Receives Regulatory Clearance To Expand CEL-SCI’S Phase 3 Head And Neck Cancer Trial Into Austria 7/8/2014 6:39:05 AM
CEL-SCI (CVM) Reports 93 Percent Increase In Sequential Quarterly Patient Enrollment In Its Phase 3 Head And Neck Cancer Trial 7/1/2014 10:35:53 AM
CEL-SCI (CVM) To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention 6/18/2014 11:30:32 AM
CEL-SCI (CVM) Reports Continued Increase In Sequential Quarterly Patient Enrollment In Its Phase 3 Head And Neck Cancer Trial 6/3/2014 9:51:14 AM
CEL-SCI (CVM) Receives Approval To Expand Its Immunotherapy Phase 3 Head And Neck Cancer Trial Into The United Kingdom 6/2/2014 10:36:47 AM
University Of Cincinnati Cancer Institute’s Comprehensive Head And Neck Cancer Center Joins CEL-SCI (CVM)’S Phase 3 Trial 5/27/2014 10:07:13 AM
CEL-SCI (CVM) Reports Second Quarter Fiscal 2014 Financial Results 5/13/2014 7:36:27 AM
12345678910...
//-->